PRODUCTS OF THE CHEMICAL OR ALLIED INDUSTRIES > ORGANIC CHEMICALS > Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds
| Code | Description | Duty |
|---|---|---|
| 2934100000 | Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure | - |
| 2934100010D | Hexythiazox (ISO)|(CAS RN 78587-05-0) | 6.500 % |
| 2934100020D | 2-(4-Methylthiazol-5-yl)ethanol (CAS RN 137-00-8) | 6.500 % |
| 2934100035D | (2-Isopropylthiazol-4-yl)-N-methylmethanamine dihydrochloride (CAS RN 1185167-55-8) | 6.500 % |
| D | 2-Cyanimino-1,3-thiazolidine (CAS RN 26364-65-8) | 6.500 % |
+90 sub-codes
| 2-(4-Methylthiazol-5-yl)ethanol (CAS RN 137-00-8) |
| 6.500 % |
| 2934100035D | (2-Isopropylthiazol-4-yl)-N-methylmethanamine dihydrochloride (CAS RN 1185167-55-8) | 6.500 % |
| 2934100045D | 2-Cyanimino-1,3-thiazolidine (CAS RN 26364-65-8) | 6.500 % |
| 2934100060D | Fosthiazate (ISO) (CAS RN 98886-44-3) | 6.500 % |
| 2934100090D | Other | 0.000 % |
| 2934200000 | Compounds containing in the structure a benzothiazole ring-system (whether or not hydrogenated), not further fused | - |
| 2934202000D | Di(benzothiazol-2-yl)disulphide; benzothiazole-2-thiol (mercaptobenzothiazole) and its salts | 6.500 % |
| 2934208000 | Other | - |
| 2934208015D | Benthiavalicarb-isopropyl (ISO) (CAS|RN|177406-68-7) | 6.500 % |
| 2934208025D | 1,2-Benzisothiazol-3(2H)-one (CAS RN 2634-33-5) in the form of a powder with a purity by weight of 95 % or more, or in an aqueous mixture containing by weight 20 % or more of 1,2-benzisothiazol-3(2H)-one | 6.500 % |
| 2934208035D | 3-Methyl-1,2-benzothiazole-1,1-dioxide (CAS RN 34989-82-7) with a purity by weight of 95 % or more | 6.500 % |
| 2934208070D | N,N-Bis(1,3-benzothiazol-2-ylsulphanyl)-2-methylpropan-2-amine (CAS RN 3741-80-8) | 6.500 % |
| 2934208090D | Other | 0.000 % |
| 2934300000 | Compounds containing in the structure a phenothiazine ring-system (whether or not hydrogenated), not further fused | - |
| 2934301000D | Thiethylperazine (INN); thioridazine (INN) and its salts | 0.000 % |
| 2934309000 | Other | - |
| 2934309010D | 2-Methylthiophenothiazine (CAS RN 7643-08-5) | 6.500 % |
| 2934309090D | Other | 0.000 % |
| 2934910000 | Other | 0.000 % |
| 2934910000D | Aminorex (INN), brotizolam (INN), clotiazepam (INN), cloxazolam (INN), dextromoramide (INN), haloxazolam (INN), ketazolam (INN), mesocarb (INN), oxazolam (INN), pemoline (INN), phendimetrazine (INN), phenmetrazine (INN) and sufentanil (INN); salts thereof | 0.000 % |
| 2934920000D | Other fentanyls and their derivatives | 0.000 % |
| 2934990000 | Other | - |
| 2934996000D | Chlorprothixene (INN); thenalidine (INN) and its tartrates and maleates; furazolidone (INN); 7-aminocephalosporanic acid; salts and esters of (6R,7R)-3-acetoxymethyl-7-[(R)-2-formyloxy-2-phenylacetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 1-[2-(1,3-dioxan-2-yl)ethyl]-2-methylpyridinium bromide | 0.000 % |
| 2934999000 | Other | - |
| 2934999004D | Silthiofam (ISO) (CAS RN 175217-20-6) with a purity by weight of 98 % or more | 6.500 % |
| 2934999005D | (S)-2-Methyl-1-(6-nitropyridin-3-yl)-4-(oxetan-3-yl)piperazine (CAS RN 1895867-67-0) with a purity by weight of 97 % or more | 6.500 % |
| 2934999006D | Cis-[2-(2,4-Dichlorodiphenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4yl]methyl-4-methylbenzenesulfonate (CAS RN 134071-44-6) with a purity by weight of 99 % or more | 6.500 % |
| 2934999007D | Cedazuridine (INN) (CAS RN 1141397-80-9) with a purity by weight of 99 % or more | 6.500 % |
| 2934999008D | (R)-tert-butyl 2-(6-(5-chloro-2-((tetrahydro-2H-pyran-4-yl)amino)pyrimidin-4-yl)-1-oxoisoindolin-2-yl)propanoate (CAS RN 2095665-45-3) with a purity by weight of 98 % or more | 6.500 % |
| 2934999009D | 3-[2-{(2R,3S)-3-[(1R)-1-{[tert-butyl(dimethyl)silyl]oxy}ethyl]-4-oxoazetidin-2-yl}propanoyl]-4,4-dimethyl-1,3-oxazolidin-2-one (isomeric mixture of CAS RNs 114341-89-8 and 114418-63-2) with a purity by weight of 99 % or more | 6.500 % |
| 2934999010D | Fluralaner (INN) (CAS RN 864731-61-3) | 6.500 % |
| 2934999011D | Aqueous solution of d(P-thio)(T-G-A-C-T-G-T-G-A-A-C-G-T-T-C-G-A-G-A-T-G-A) deoxyribonucleic acid (CAS RN 937402-51-2), containing by weight 15 % or more, but not more than 25 % of oligodeoxynucleotide | 6.500 % |
| 2934999012D | Dimethomorph (ISO) (CAS RN 110488-70-5) | 6.500 % |
| 2934999013D | (6S)-6-methyl-5,6-Dihydro-4H-thieno[2,3-b]thiopyran4-one-7,7-dioxide (CAS RN 148719-91-9) with a purity by weight of 98 % or more | 6.500 % |
| 2934999014D | 2-Mercaptoadenosine (CAS RN 43157-50-2) with a purity by weight of 98 % or more | 6.500 % |
| 2934999016D | Difenoconazole (ISO) (CAS RN 119446-68-3) | 6.500 % |
| 2934999017D | (S)-4-(tert-butoxycarbonyl)-1,4-oxazepane-2-carboxylic acid (CAS RN 1273567-44-4) with a purity by weight of 95 % or more | 6.500 % |
| 2934999018D | Methyl (1R,3R)-1-(1,3-benzodioxol-5-yl)-2-(2-chloroacetyl)-1,3,4,9-tetrahydropyrido[5,4-b]indole-3-carboxylate (CAS RN 171489-59-1) with a purity by weight of 99 % or more | 6.500 % |
| 2934999019D | (4R,6S)-6-Methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-4-ol (CAS RN 147128-77-6) with a purity by weight of 94 % or more | 6.500 % |
| 2934999020D | Thiophene (CAS RN 110-02-1) | 6.500 % |
| 2934999021D | Acesulfame potassium (potassium salt of 6-methyl-1,2,3-oxathiazin-4(3H)-one 2,2-dioxide; CAS RN 55589-62-3) ace-K | 0.000 % |
| 2934999022D | 4-(Oxiran-2-ylmethoxy)-9H-carbazole (CAS RN 51997-51-4) with a purity by weight of 97 % or more | 6.500 % |
| 2934999024D | Flufenacet (ISO) (CAS RN 142459-58-3) with a purity by weight of 95 % or more | 6.500 % |
| 2934999026D | 4-Methylmorpholine 4-oxide in an aqueous solution (CAS RN 7529-22-8) | 6.500 % |
| 2934999027D | 2-(4-Hydroxyphenyl)-1-benzothiophene-6-ol (CAS RN 63676-22-2) | 6.500 % |
| 2934999028D | 11-(Piperazin-1-yl)dibenzo[b,f][1,4]thiazepine dihydrochloride|(CAS RN 111974-74-4) | 6.500 % |
| 2934999030D | Dibenzo[b,f][1,4]thiazepin-11(10H)-one (CAS RN 3159-07-7) | 6.500 % |
| 2934999031D | Thenoic acid (CAS RN 1918-77-0) with a purity by weight of 97 % or more | 6.500 % |
| 2934999032D | (6R,7R)-Benzhydryl 3-hydroxy-8-oxo-7-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (CAS RN 54639-48-4) with a purity by weight of 95 % or more | 6.500 % |
| 2934999034D | Benzyl 4-(oxetan-3-yl)piperazine-1-carboxylate (CAS RN 1254115-22-4) with a purity by weight of 99 % or more | 6.500 % |
| 2934999035D | Nusinersen sodium (INNM) (CAS RN 1258984-36-9) with a purity by weight of 95 % or more | 6.500 % |
| 2934999036D | Nadide phosphate (INNM) disodium salt (CAS RN 24292-60-2) with a purity by weight of 97 % or more | 6.500 % |
| 2934999037D | 4-Propan-2-ylmorpholine (CAS RN 1004-14-4) | 6.500 % |
| 2934999038D | 2-Chloro-9H-thioxanthen-9-one (CAS RN 86-39-5) with a purity by weight of 98 % or more | 6.500 % |
| 2934999039D | 4-(Oxiran-2-ylmethoxy)-9H-carbazole (CAS RN 51997-51-4) | 6.500 % |
| 2934999040D | 2,3-Pyrazinedicarboxylic anhydride (CAS RN 4744-50-7) with a purity by weight of 95 % or more | 6.500 % |
| 2934999041D | 11-[4-(2-Chloro-ethyl)-1-piperazinyl]dibenzo(b,f)(1,4)thiazepine (CAS RN 352232-17-8) | 6.500 % |
| 2934999045D | 4-[4-[(5s)-5-(Aminomethyl)-2-oxo-3-oxazolidinyl] phenyl]-3-morpholinone, hydrochloride (CAS RN 898543-06-1) with a purity by weight of 98 % or more | 6.500 % |
| 2934999046D | (6R-trans)-7-Amino-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (CAS RN 58909-56-1) with a purity by weight of 97 % or more | 6.500 % |
| 2934999047D | 2,4-Diethyl-9H-thioxanthen-9-one (CAS RN 82799-44-8) with a purity by weight of 97 % or more | 6.500 % |
| 2934999048D | Propan-2-ol|--|2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine (1:2) dihydrate, (CAS RN 864743-41-9) | 6.500 % |
| 2934999049D | Cytidine 5'-(disodium phosphate) (CAS RN 6757-06-8) | 6.500 % |
| 2934999050D | Vutrisiran (INN) (CAS RN 1867157-35-4) with a purity by weight of 98 % or more | 6.500 % |
| 2934999051D | Uridine 5'-triphosphate trisodium salt (CAS RN 19817-92-6) with a dry weight purity of 90 % or more | 6.500 % |
| 2934999055D | Uridine (CAS RN 58-96-8) with a purity by weight of 98 % or more | 6.500 % |
| 2934999056D | 1-[5-(2,6-Difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]ethanone (CAS RN 1173693-36-1) | 6.500 % |
| 2934999057D | Dimethenamide-P (ISO) (CAS RN 163515-14-8) with a purity by weight of 93 % or more | 6.500 % |
| 2934999059D | Dolutegravir (INN) (CAS|RN|1051375-16-6) or dolutegravir sodium (CAS|RN|1051375-19-9) | 6.500 % |
| 2934999060D | DL-Homocysteine thiolactone hydrochloride|(CAS RN 6038-19-3) | 6.500 % |
| 2934999061D | 5-(1,2-dithiolan-3-yl)valeric acid (CAS RN 1077-28-7) | 6.500 % |
| 2934999063D | (2b,3a,5a,16b,17b)-2-(morpholin-4-yl)-16-(pyrrolidin-1-yl)androstane-3,17-diol (CAS|RN|119302-20-4) | 6.500 % |
| 2934999064D | 2-Bromo-5-benzoylthiophene (CAS RN 31161-46-3) | 6.500 % |
| 2934999065D | Benzo[b]thiophen-10-methoxycycloheptanone (CAS RN 59743-84-9) with a purity by weight of 98 % or more | 6.500 % |
| 2934999066D | Tetrahydrothiophene-1,1-dioxide (CAS RN 126-33-0) | 6.500 % |
| 2934999067D | 5-Chlorothiophene-2-carboxylic acid (CAS RN 24065-33-6) | 6.500 % |
| 2934999069D | 3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazol-2(3H)-one (CAS RN 1220696-32-1) with a purity by weight of 95 % or more | 6.500 % |
| 2934999070D | 1,3,4-thiadiazolidine-2,5-dithione (CAS RN 1072-71-5) with a purity by weight of 95 % or more | 6.500 % |
| 2934999071D | 3,4-Dichloro-1,2,5-thiadiazole (CAS RN 5728-20-1) with a purity by weight of 99 % or more | 6.500 % |
| 2934999072D | 2-Trifluoromethyl-9-allyl-9-thioxanthen-ol (CAS RN 850808-70-7) with a purity by weight of 98 % or more | 6.500 % |
| 2934999074D | 2-Isopropylthioxanthone (CAS RN 5495-84-1) | 6.500 % |
| 2934999075D | (4R-cis)-1,1-Dimethylethyl-6-[2[2-(4-fluorophenyl)-5-(1-isopropyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetate (CAS RN 125971-95-1) | 6.500 % |
| 2934999076D | Nedosiran sodium (INNM) (CAS RN 2247026-22-6) with a purity by weight of 95 % or more | 6.500 % |
| 2934999077D | Tazemetostat (INN) (CAS 1403254-99-8) with a purity by weight of 99 % or more and its salts | 6.500 % |
| 2934999078D | Disodium uridine-5'-monophosphate (CAS RN 3387-36-8) with a purity by weight of 98 % or more | 6.500 % |
| 2934999081D | 1-(4-aminophenyl)-5-(morpholin-4-yl)-2,3-dihydropyridin-6-one (CAS RN 1267610-26-3) with a purity by weight of 98 % or more | 6.500 % |
| 2934999082D | Rel-(3aR,12bR)-11-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one (CAS RN 129385-59-7) with a purity by weight of 97 % or more | 6.500 % |
| 2934999083D | Flumioxazin (ISO) (CAS RN 103361-09-7) of a purity by weight of 96 % or more | 6.500 % |
| 2934999085D | Gilteritinib (INN) (CAS 1254053-43-4) with a purity by weight of 98 % or more and its salts | 6.500 % |
| 2934999086D | Dithianon (ISO) (CAS RN 3347-22-6) | 6.500 % |
| 2934999087D | 2,2'-(1,4-Phenylene)bis(4H-3,1-benzoxazin-4-one) (CAS RN 18600-59-4) | 6.500 % |
| 2934999088D | (7S,9aS)-7-((benzyloxy)methyl)octahydropyrazino[2,1-c][1,4]oxazine dioxalate (CAS RN 1268364-46-0) | 6.500 % |
| 2934999089D | 6R-[6α,7β(Z)]]-7-[2-Furyl(methoxyimino)acetamido]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (CAS RN 56271-94-4) with a purity by weight of 96 % or more | 6.500 % |
| 2934999090D | Other | 0.000 % |